%0 Journal Article
%T The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib
%A Alshad S. Lalani
%A Andrew Poklepovic
%A Cindy Sander
%A Francesca Avogadri-Connors
%A Jane L. Roberts
%A John Kirkwood
%A Laurence Booth
%A Paul Dent
%A Richard E. Cutler Jr
%J Archive of "Cancer Biology & Therapy".
%D 2018
%R 10.1080/15384047.2017.1394556
%K autophagy
%K HDAC
%K RAS
%K receptor tyrosine kinase
%K neratinib
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790370/